Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9706 | 1063 | 38.9 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2116 | 4671 | ANGIOTENSINOGEN//ANGIOTENSIN CONVERTING ENZYME//ANGIOTENSINOGEN GENE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ADRB2 | Author keyword | 31 | 61% | 3% | 33 |
2 | BETA2 ADRENERGIC RECEPTOR | Author keyword | 27 | 26% | 8% | 89 |
3 | BETA 2 ADRENERGIC RECEPTOR GENE | Author keyword | 17 | 79% | 1% | 11 |
4 | ADRB1 | Author keyword | 17 | 70% | 1% | 14 |
5 | CARDIOPULM GENOM PROGRAM | Address | 14 | 57% | 2% | 17 |
6 | GLN27GLU POLYMORPHISM | Author keyword | 14 | 100% | 1% | 7 |
7 | BETA2 ADRENERGIC RECEPTOR GENE | Author keyword | 13 | 80% | 1% | 8 |
8 | BETA2 ADRENOCEPTOR POLYMORPHISM | Author keyword | 13 | 80% | 1% | 8 |
9 | RESPONSE HETEROGENEITY | Author keyword | 12 | 86% | 1% | 6 |
10 | BETA 2 ADRENORECEPTOR | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN BETA2 ADRENERGIC RECEPTOR | 116 | 66% | 10% | 108 |
2 | HUMAN BETA1 ADRENERGIC RECEPTOR | 68 | 65% | 6% | 65 |
3 | GLN27GLU | 45 | 94% | 2% | 16 |
4 | ARG16GLY POLYMORPHISM | 41 | 87% | 2% | 20 |
5 | SYNERGISTIC POLYMORPHISMS | 41 | 100% | 1% | 15 |
6 | ADRENOCEPTOR POLYMORPHISMS | 35 | 86% | 2% | 18 |
7 | 5 LEADER CISTRON | 34 | 93% | 1% | 13 |
8 | BETA2 ADRENERGIC RECEPTOR POLYMORPHISMS | 31 | 66% | 3% | 29 |
9 | ADRENERGIC RECEPTOR POLYMORPHISMS | 26 | 69% | 2% | 22 |
10 | BETA2 AGONIST THERAPY | 25 | 71% | 2% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacogenomics in Asthma Therapy: Where Are We and Where Do We Go? | 2015 | 3 | 85 | 35% |
beta-1 and beta-2 adrenoceptor polymorphisms: Functional importance, impact on cardiovascular diseases and drug responses | 2008 | 73 | 171 | 85% |
Systematic review and meta-analysis of the association between beta(2)-adrenoceptor polymorphisms and asthma: A HuGE review | 2005 | 224 | 50 | 60% |
Pharmacology and physiology of human adrenergic receptor polymorphisms | 2003 | 194 | 103 | 69% |
Role of beta adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis | 2008 | 43 | 77 | 66% |
Clinical consequences of ADR beta 2 polymorphisms | 2008 | 29 | 47 | 85% |
beta(1)- and beta(2)-Adrenoceptor polymorphisms and cardiovascular diseases | 2009 | 24 | 47 | 81% |
Pharmacogenetics of beta 2 adrenergic receptor gene polymorphisms, long-acting beta-agonists and asthma | 2011 | 20 | 85 | 64% |
Cardiac adrenoceptors: Physiological and pathophysiological relevance | 2006 | 117 | 112 | 46% |
Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation | 2006 | 146 | 21 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOPULM GENOM PROGRAM | 14 | 57% | 1.6% | 17 |
2 | CLIN PEDIAT PHARMACOL | 2 | 36% | 0.4% | 4 |
3 | CLIN PEDIAT PHARMACOL PHARMACOGENET | 1 | 50% | 0.2% | 2 |
4 | DUKE PERIOPERAT GENOM PROGRAM | 1 | 50% | 0.2% | 2 |
5 | GRP INSUFICIENCIA CARDIACA TRANSPLANTE | 1 | 100% | 0.2% | 2 |
6 | MOL BIOL CARDIOL UNIT | 1 | 100% | 0.2% | 2 |
7 | PEDIAT PULMONOL PEDIAT ALLERGOLBEATRIX CH | 1 | 100% | 0.2% | 2 |
8 | POPULAT PHARMACOGENET GRP | 1 | 14% | 0.7% | 7 |
9 | CHILDRENS ASTHMA ALLERGY UNIT | 1 | 33% | 0.2% | 2 |
10 | PERSONALIZED MED GENOM | 1 | 33% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000139964 | BETA3 ADRENERGIC RECEPTOR GENE//TRP64ARG POLYMORPHISM//BETA3 ADRENERGIC RECEPTOR |
2 | 0.0000109249 | FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL |
3 | 0.0000106180 | ADAM33//ORMDL3//ASTHMA GENET GRP |
4 | 0.0000095205 | GNB3//ADDUCIN//G PROTEIN BETA 3 SUBUNIT |
5 | 0.0000083728 | ALPHA2 ADRENOCEPTOR SUBTYPES//ALPHA2 ADRENOCEPTOR SUBTYPE//ALPHA2C ADRENOCEPTOR |
6 | 0.0000064158 | PHARMACOGENOMICS//PERSONALIZED MEDICINE//PROGRAM PERSONALIZED MED TARGETED THER EUT |
7 | 0.0000064003 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
8 | 0.0000063331 | HAIR DISTRIBUTION//PHYS ACT SPORT RECREAT PHASREC//HART |
9 | 0.0000060267 | GPRC5A//GNAS1//CELLULAR SIGNALINGCANC |
10 | 0.0000053366 | CARVEDILOL//BUCINDOLOL//CARVEDILOL ENANTIOMERS |